期刊文献+

Diverse roles of macrophages in intraocular neovasculardiseases:a review 被引量:6

Diverse roles of macrophages in intraocular neovascular diseases:a review
在线阅读 下载PDF
导出
摘要 Macrophages are involved in angiogenesis, and might also contribute to the pathogenesis of intraocular neovascular diseases. Recent studies indicated that macrophages exert different functions in the process of intraocular neovascularization, and the polarization of M1 and M2 phenotypes plays extremely essential roles in the diverse functions of macrophages. Moreover, a large number of cytokines released by macrophages not only participate in macrophage polarization, but also associate with retinal and choroidal neovascular diseases. Therefore, macrophage might be considered as a novel therapeutic target to the treatment of pathological neovascularization in the eye. This review mainly summarizes diverse roles of macrophages and discusses the possible mechanisms in retinal and choroidal neovascularization. Macrophages are involved in angiogenesis, and might also contribute to the pathogenesis of intraocular neovascular diseases. Recent studies indicated that macrophages exert different functions in the process of intraocular neovascularization, and the polarization of M1 and M2 phenotypes plays extremely essential roles in the diverse functions of macrophages. Moreover, a large number of cytokines released by macrophages not only participate in macrophage polarization, but also associate with retinal and choroidal neovascular diseases. Therefore, macrophage might be considered as a novel therapeutic target to the treatment of pathological neovascularization in the eye. This review mainly summarizes diverse roles of macrophages and discusses the possible mechanisms in retinal and choroidal neovascularization.
出处 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2017年第12期1902-1908,共7页 国际眼科杂志(英文版)
基金 Supported by National Natural Science Foundation of China(No.81371036 No.81700837) Department of Science and Technology,Hunan(No.2015TP2007) Japan Society for the Promotion of Science KAKENHI Grants(No.26293374 No.16K15734)
关键词 MACROPHAGE retinal neovascularization choroidal neovascularization proliferative diabetic retinopathy retinopathy ofprematurity age-related macular degeneration macrophage retinal neovascularization choroidal neovascularization proliferative diabetic retinopathy retinopathy ofprematurity age-related macular degeneration
作者简介 Correspondence to: Ye-Di Zhou. Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China. zhouyedi@csu. edu.cn; Shigeo Yoshida. Department of Ophthalmology, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan. yosida@med.kyushu-u.ac.jp
  • 相关文献

参考文献1

二级参考文献83

  • 1Hosseini H, Nowroozzadeh MH, Salouti R, Nejabat M. Anti- vegf therapy with bevacizumab for anterior segment eye disease. Cornea 2012, 31: 322-334.
  • 2Stewart MW. The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clinic proceedings.Mayo Clinic 2012, 87: 77-88.
  • 3Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 2007, 18: 502-508.
  • 4Ferrara N, Damico L, Shams N, Lowman H, Kim R. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 2006, 26: 859-870.
  • 5Miller JW. Vascular endothelial growth factor and ocular neovascularization. American J Pathol 1997, 151 : 13-23.
  • 6Keane PA, Sadda SR. Development of anti-vegf therapies for intraocular use: A guide for clinicians. J Ophthalmol 2012, 2012: 483034.
  • 7Ferrara N. Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy. Nat Med 2010, 16: 1107-1111.
  • 8Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991, 266:11947-11954.
  • 9Ferrara N, Gerber HP, LeCouter J. The biology of vegf and its receptors. Nat Med 2003, 9: 669-676.
  • 10Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, Adamis AE Pegaptanib, a targeted anti-vegf aptamer for ocular vascular disease. Nature Rev. Drug discovery 2006, 5: 123-132.

共引文献8

同被引文献13

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部